StockData
Medicenna Therapeutics Corp. logo

Medicenna Therapeutics Corp. (MDNAF) stock

MDNAFOTCPharmaceutical PreparationsFiscal year ends March 31
Financials through fiscal 2023, year ended Mar 31, 2023Last filing: 20-F on Jun 27, 2023
$0.28−0.02 (-7.63%)

Close on Oct 19, 2026

Medicenna Therapeutics shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

For fiscal 2023 it was 65M, up 19.2% from the year before.

Annual shares outstanding

PeriodPeriod endValueChange
FY2023Mar 31, 202365M+19.2%
FY2022Mar 31, 202254M+9.3%
FY2021Mar 31, 202150M+55.7%
FY2020Mar 31, 202032M–

More Medicenna Therapeutics figures

See a number that looks wrong?